Nottingham trial of faecal occult blood testing for colorectal cancer: A 20-year follow-up

Gut

Volumn 61, Issue 7, 2012, Pages 1036-1040

  Scholefield, J H ^a   Moss, S M ^b   Mangham, C M ^a   Whynes, D K ^c   Hardcastle, J D ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Cancer Screening Evaluation Unit   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURGERY; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OCCULT BLOOD TEST; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOMA; AGED; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTENTION TO TREAT ANALYSIS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SURVIVAL RATE;

EID: 84861573867     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300774     Document Type: Article

References (12)

1. Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50:29-32. (Pubitemid 34028299)
2. Mandel JS, Church TR, Ederer F, et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7. (Pubitemid 29128279)
3. Scholefield JH, Moss S, Sufi F, et al. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 2002;50:840-4. (Pubitemid 34539047)
4. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. In: The Cochrane Library. Issue 3. 2008.
5. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7. (Pubitemid 26400242)
6. Robinson MH, Rodrigues VC, Hardcastle JD, et al. Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process. J Med Screen 2000;7:97-8.
7. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997;16:1017-29. (Pubitemid 27198989)
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71. (Pubitemid 23131388)
9. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
10. Robinson MH, Hardcastle JD, Moss SM, et al. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588-92. (Pubitemid 29447830)
11. Parker MA, Robinson MH, Scholefield JH, et al. Psychiatric morbidity and screening for colorectal cancer. J Med Screen 2002;9:7-10. (Pubitemid 34327135)
12. Moss SM, Hardcastle JD, Coleman DA, et al. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol 1999;28:386-90. (Pubitemid 29276694)